Total serum IL-12 and IL-12p40, but not IL-12p70, are increased in the serum of older subjects; Relationship to CD3+ and NK subsets

Cytokine

Volumn 12, Issue 2, 2000, Pages 156-159

  Rea, I M ^a   McNerlan, S E ^a   Alexander, H D ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

Aging; CD3+ lymphocytes; IL 12p40; IL 12p70; Total IL 12

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 12; PROTEIN SUBUNIT;

ADULT; AGE; AGED; AGING; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0033948476     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0537     Document Type: Article

References (24)

1. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clarke SC, Chan S, Loudon R, Sherman P, Perussia R, Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med. 170:1989;827-846.
2. Stern AS, Podlaski FJ, Hulmes JD, Pan YE, Quinn PM, Wolitzky AG, Familletti PC, Stremlo DL, Truitt T, Chizzonite R, Gately MK. Purification to homogeneity and partial characterisation of cytotoxic lymphocyte maturation factor from human B-Lymphoblastoid cells. Proc Natl Acad Sci U S A. 87:1990;6808-6812.
3. Trinchieri G. Interleukin-12 and its role in the generation of Th1 cells. Immunol Today. 14:1993;335-338.
4. Wolf SF, Temple PA, Kobayashi M, Young D, Dicig M, Lowe L, Dzialo R, Fitz L, Ferenz C, Hewick M, Kelleher K, Hermann SH, Clark SC, Assoni L, Chan SH, Chan G, Trinchieri G, Perussia B. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol. 146:1991;3074-3078.
5. Bette M, Jin SC, Germann T, Schafer MK-H, Weihe E, Rude E, Fleischer B. Differential expression of mRNA encoding Interleukin-12 p35 and p40 subunits in situ. Eur J Immunol. 24:1994;2435-2440.
6. Gillessen S, Carvajal D, Ling P, Podlaski FJ, Stremlo DL, Familletti PC, Gubler U, Presky DH, Stern AS, Gately MK. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur J Immunol. 25:1995;200-206.
7. Mattner F, Fischer S, Jin S, Kaulen H, Schmitt E, Rude E, Germann T. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur J Immunol. 23:1993;2202-2208.
8. Kato K, Shimozato O, Hoshi K, Wakimoto H, Hamada H, Yagita H, Okumura K. Local production of the p40 subunit of Interleukin-12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejection. Proc Natl Acad Sci U S A. 93:1996;9085-9089.
9. Jansen PM, van der Pouw Kraan TC, de Jong IW, van Mierlo G, Wijdenes J, Chang AA, Aarden LA, Taylor FB Jr, Hack CE. Release of interleukin-12 in experimental Escherichia Coli septic shock in baboons: Relation to plasma levels of Interleukin-10 and IFNγ Blood. 87:1996;5144-5151.
10. Dudley DJ, Hunter C, Mitchell MD, Varner MW, Gately M. Elevation of serum interleukin-12 concentration in women with severe pre-eclampsia and HELLP syndrome. J Reprod Immunol. 31:1996;97-107.
11. Remarque E, Pawelec G. T-cell immunosenesence and its clinical significance. Rev Clin Gerontol. 8:1998;5-15.
12. Rea IM, Stewart M, Campbell P, Alexander HD, Morris TCM. Changes in lymphocyte subsets, interleukin 2 and soluble interleukin 2 receptor in old and very old age. Gerontol. 42:1996;69-78.
13. Sansoni P, Cozzarizza A, Brianti V, Fagnoni F, Snelli G, Monti D, Marcato A, Passeri G, Ortolani C, Forti E, Fagioli U, Passeri M, Francheschi C. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood. 82:1993;2767-2773.
14. +CD57+ subset and related cytokines in healthy aging. J Clin Immunol. 18:1998;31-38.
15. Rea IM, McNerlan SE, Alexander HD. CD69, CD25 and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNFα, IFNγ and sIL-2R levels in aging. Exp Gerontol. 34:1999;79-93.
16. Rubin A, Nelson DL. The soluble Interleukin-2 receptor; Biology, function and clinical applications. Ann Intern Med. 113:1990;619-627.
17. Trinchieri G, Peritt D, Gerosa F. Acute induction and priming for cytokine production in lymphocytes. Cytokine Growth Factor Rev. 7:1996;123-132.
18. Daynes RA, Araneo BA, Ershler WB, Maloney CD, Li GZ, Ryu SY. A dysregulation in the production of Interleukin-6 with normal aging. Probable linkage to age-associated depression in dehydroepiandrosterone (DHEA) and its sulphated derivative. J Immunol. 150:1993;5219-5225.
19. O'Mahoney L, Holland J, Jackson J, Fieghery C, Hennessy TPJ, Mealy K. Quantitative intracellular cytokine measurement: age-related change in pro-inflammatory cytokine production. Clin Exp Immunol. 113:1998;213-219.
20. Rea IM, McNerlan SE, Alexander HD, Morris TCM. Serum Tumour Necrosis factor (TNFα) and soluble Interleukin-2 Receptor (sIL-2R) are increased in elderly subjects. Immunol Lett. 56:1997;285.
21. Pioll C, Pucci S, Barile S, Frasca D, Doria G. Role of mRNA stability in the different patterns of cytokine production by CD4+ cells from young and old mice. Immunology. 94:1998;380-387.
22. Folstein MF, Folstein SE, McHugh PR. Mini Mental State, a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 12:1975;189-193.
23. Lighhart GL, Corberand JX, Fournier C, Galanaud P, Hifmans W, Kennes B, Muller P, Hermelink HK, Steinmann GG. Admission criteria for immunogerontological studies in man: The Senieur Protocol. Mech Aging Dev. 28:1984;47-52.
24. Rea IM, Middleton D. Is the phenotypic combination A1B8Cw7DR3 a marker for male longevity? JAGS. 42:1994;987-991.